|
CantilDrug - Cantil The trade name of the product as shown on the labeling.
Dosage -
SOLUTION; ORAL
Active Ingredient(s) -
Mepenzolate Bromide
Strength -
25MG/5ML
Applicant -
AVENTIS PHARMS
New Drug Application (NDA) Number -
010679
Product Number -
004
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Aventis Pharmaceuticals Inc
Cantil
Repronex 75 Iu/vial;75 Iu/vial Injectable; Im-sc
Humegon 150 Iu/vial;150 Iu/vial Injectable; Injection Humegon 75 Iu/vial;75 Iu/vial Injectable; Injection Menotropins 150 Iu/vial;150 Iu/vial Injectable; Injection Menotropins 75 Iu/vial;75 Iu/vial Injectable; Injection Pergonal 150 Iu/amp;150 Iu/amp Injectable; Injection Pergonal 75 Iu/amp;75 Iu/amp Injectable; Injection Repronex 150 Iu/vial;150 Iu/vial Injectable; Injection Menopur 75 Iu/vial;75 Iu/vial Injectable; Subcutaneous Cantil 25mg/5ml Solution; Oral NewDrugInformation |